Neuronal cell lines transfected with the dopamine D2 receptor gene promoter as a model for studying the effects of antidepressant drugs

Molecular Brain Research

Volumn 128, Issue 1, 2004, Pages 75-82

  Dziedzicka Wasylewska, Marta ^a   Solich, Joanna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant drugs; Dopamine D2 receptor; Neuronal cell lines; Neurotransmitters, modulators, transporters, and receptors; Signal tranduction: gene expression; Transcriptional activity

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLIC AMP DEPENDENT PROTEIN KINASE; DESIPRAMINE; DOPAMINE 2 RECEPTOR; FORSKOLIN; LUCIFERASE; MIANSERIN; NORADRENALIN UPTAKE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; ROLIPRAM; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE D2 RECEPTOR GENE; DRUG EFFECT; EXPOSURE; FRAGMENTATION REACTION; GENE; GENE CONSTRUCT; GENE CONTROL; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR MODEL; NERVE CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 4344684789     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.06.006     Document Type: Article

References (32)

1. Ainsworth K., Smith S.E., Zetterstrom T.S.C., Pei Q., Franklin M., Sharp T. Effect of antidepressant drugs on dopamine D1 and D2 receptors expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology. 140:1998;470-477
2. Al-Damluji S., Kopin I.J. Binding and competitive inhibition of amine uptake at post-synaptic neurons (Transport-P) by tricyclic antidepressant. Br. J. Pharmacol. 117:1996;811-816
3. Budziszewska B., Jaworska-Feil L., Kajta M., Lasoń W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Br. J. Pharmacol. 130:2000;1385-1393
4. Daniel W., Adamus A., Melzacka M., Szymura J., Vetulani J. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;209-213
5. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 405:2000;365-373
6. De Wet J.R., Wood K.V., De Luca M., Helinski D.R., Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:1987;725-737
7. Dowlatshahi D., MacQueen G.M., Wang J.F., Young T.L. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 352:1998;1754-1755
8. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular hypothesis of depression. Arch. Gen. Psychiatry. 54:1997;597-606
9. Dynan W.S. Promoters for housekeeping genes. Trends Genet. 2:1986;196-197
10. 2 dopamine receptors in the rat brain. J. Neural Transm. 104:1997;515-524
11. Dziedzicka-Wasylewska M., Willner P., Papp M. Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav. Pharmacol. 8:1997b;607-618
12. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28:1998;370-460
13. Kornhuber J., Retz W., Riederer P. Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs? J. Neural Transm., Suppl. 46:1995;315-323
14. 3 receptor gene expression as a common effect of chronic antidepressant treatment. Mol. Psychiatry. 5:2000;378-388
15. Maj J. Behavioural effects of antidepressant drugs given repeatedly on the dopaminergic system. Adv. Biosci. 77:1990;139-145
16. 2 receptors in the rat brain. Eur. J. Pharmacol. 304:1996;49-54
17. 3 receptors in the rat brain. Eur. J. Pharmacol. 351:1998;31-37
18. Minowa M.T., Minowa T., Monsma F.J., Sibley D.R., Mouradian M.M. Characterization of the 5′ flanking region of the human D1A dopamine receptor gene. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3045-3049
19. 2 dopamine receptor gene. Biochemistry. 31:1992;8389-8396
20. 2 dopamine receptor gene. J. Biol. Chem. 269:1993;11656-11662
21. Monsma F.J., Brassard D.L., Sibley D.R. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines. Brain Res. 492:1989;314-324
22. Nestler E.J., Barrot M., DiLeone R.J., Eish A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron. 34:2002;13-25
23. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of CREB in rat hippocampus. J. Neurosci. 16:1996;2365-2372
24. Novelli A., Lysko P.G., Hanneberry R.C. Uptake of imipramine in neurons cultured from rat cerebellum. Brain Res. 411:1987;291-297
25. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., Kerwin R.W. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol. 134:2001;1335-1343
26. 3 receptors in the rat brain differentiated by agonist and antagonist binding - an autoradiographic analysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;178-186
27. 2 receptor promoters by members of the retinoic acid receptor-retinoid X receptor family. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14354-14394
28. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed.:1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
29. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47:1995;1112-1118
30. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20:2000;4030-4036
31. 2 receptor gene from two promoters. Eur. J. Biochem. 220:1994;577-584
32. Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int. Clin. Psychopharmacol. Suppl. 3:1997;S7-S14